// App-Quantinova.ai

FRI0314 : ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) CLINICAL DATABASE AND REPOSITORY ANALYSIS: THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS ON THE CLINICAL PHENOTYPE OF ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PATIENTS

Researchers

Presenter

  • S. Zuily

Principal Investigators

  • D. Andrade

  • D. Erkan

  • M. Tektonidou

Medical Centers

  • First Department of Propaedeutic Medicine, University of Athens, Athens, Greece

  • Dept. of Rheumatology, Sao Paulo, Brazil

  • Hospital for Special Surgery, New York, New York , United States

  • Vascular Medicine Division and Inserm U, Nancy University Hospital, Vandoeuvre les Nancy Cedex, France

Locations

  • Brazil

  • United States

  • France

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Autoimmune hemolytic anemia

  • Antiphospholipid syndrome

  • Microvascular complications of diabetes 1

  • End stage renal disease

  • Nephrotic syndrome

  • Thrombocytopenia

  • Renal disease

  • Venous thrombosis

  • Anemia

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved